<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39163767</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-2317</ISSN><JournalIssue CitedMedium="Internet"><Volume>76</Volume><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Redox biology</Title><ISOAbbreviation>Redox Biol</ISOAbbreviation></Journal><ArticleTitle>Systemic oxidative stress associates with the development of post-COVID-19 syndrome in non-hospitalized individuals.</ArticleTitle><Pagination><StartPage>103310</StartPage><MedlinePgn>103310</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">103310</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.redox.2024.103310</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-2317(24)00288-X</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Post-COVID-19 syndrome (PCS) remains a major health issue worldwide, while its pathophysiology is still poorly understood. Systemic oxidative stress (OS) may be involved in PCS, which is reflected by lower circulating free thiols (R-SH, sulfhydryl groups), as they are receptive to rapid oxidation by reactive species. This study aimed to investigate the longitudinal dynamics of serum R-SH after SARS-CoV-2 infection and its association with the development of PCS in individuals with mild COVID-19.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Baseline serum R-SH concentrations were measured and compared between 135 non-hospitalized COVID-19 subjects and 82 healthy controls (HC). In COVID-19 subjects, serum R-SH concentrations were longitudinally measured during the acute disease phase (up to 3 weeks) and at 3, 6, and 12 months of follow-up, and their associations with relevant clinical parameters were investigated, including the development of PCS.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Baseline albumin-adjusted serum R-SH were significantly reduced in non-hospitalized COVID-19 subjects as compared to HC (p&#xa0;=&#xa0;0.041), reflecting systemic OS. In mild COVID-19 subjects, trajectories of albumin-adjusted serum R-SH levels over a course of 12 months were longitudinally associated with the future presence of PCS 18 months after initial infection (b&#xa0;=&#xa0;-9.48, p&#xa0;=&#xa0;0.023).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Non-hospitalized individuals with COVID-19 show evidence of systemic oxidative stress, which is longitudinally associated with the development of PCS. Our results provide a rationale for future studies to further investigate the value of R-SH as a monitoring biomarker and a potential therapeutic target in the development of PCS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vlaming-van Eijk</LastName><ForeName>Larissa E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>University of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bulthuis</LastName><ForeName>Marian L C</ForeName><Initials>MLC</Initials><AffiliationInfo><Affiliation>University of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Gun</LastName><ForeName>Bernardina T F</ForeName><Initials>BTF</Initials><AffiliationInfo><Affiliation>University of Groningen, University Medical Center Groningen, Department of Medical Microbiology and Infection Prevention, Groningen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wold</LastName><ForeName>Karin I</ForeName><Initials>KI</Initials><AffiliationInfo><Affiliation>University of Groningen, University Medical Center Groningen, Department of Medical Microbiology and Infection Prevention, Groningen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veloo</LastName><ForeName>Alida C M</ForeName><Initials>ACM</Initials><AffiliationInfo><Affiliation>University of Groningen, University Medical Center Groningen, Department of Medical Microbiology and Infection Prevention, Groningen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vincenti Gonz&#xe1;lez</LastName><ForeName>Mar&#xed;a F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>University of Groningen, University Medical Center Groningen, Department of Medical Microbiology and Infection Prevention, Groningen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Borst</LastName><ForeName>Martin H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>University of Groningen, University Medical Center Groningen, Department of Internal Medicine, Division of Nephrology, Groningen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>den Dunnen</LastName><ForeName>Wilfred F A</ForeName><Initials>WFA</Initials><AffiliationInfo><Affiliation>University of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hillebrands</LastName><ForeName>Jan-Luuk</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>University of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Goor</LastName><ForeName>Harry</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tami</LastName><ForeName>Adriana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Groningen, University Medical Center Groningen, Department of Medical Microbiology and Infection Prevention, Groningen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bourgonje</LastName><ForeName>Arno R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>University of Groningen, University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, the Netherlands; The Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States. Electronic address: a.r.bourgonje@umcg.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Redox Biol</MedlineTA><NlmUniqueID>101605639</NlmUniqueID><ISSNLinking>2213-2317</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013438">Sulfhydryl Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="Y">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013438" MajorTopicYN="N">Sulfhydryl Compounds</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Coronavirus disease 2019</Keyword><Keyword MajorTopicYN="N">Long COVID-19</Keyword><Keyword MajorTopicYN="N">Oxidative stress</Keyword><Keyword MajorTopicYN="N">Post-COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">Redox</Keyword></KeywordList><CoiStatement>Declaration of competing interest A.R.B. has received a research grant from Janssen Pharmaceuticals and received speaker's fees from AbbVie, outside the submitted work. All other authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>13</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>21</Day><Hour>3</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>20</Day><Hour>18</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39163767</ArticleId><ArticleId IdType="pmc">PMC11381883</ArticleId><ArticleId IdType="doi">10.1016/j.redox.2024.103310</ArticleId><ArticleId IdType="pii">S2213-2317(24)00288-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO. Post COVID-19 Condition (Long COVID) Available from: https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition#:&#x223c;:text=It%20is%20defined%20as%20the,months%20with%20no%20other%20explanation. Accessed 24 April 2024.</Citation></Reference><Reference><Citation>Blomberg B., Mohn K.G., Brokstad K.A., et al. Long COVID in a prospective cohort of home-isolated patients. Nat. Med. 2021 doi: 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirchberger I., Meisinger C., Warm T.D., Hyhlik-D&#xfc;rr A., Linseisen J., Go&#xdf;lau Y. Post-COVID-19 syndrome in non-hospitalized individuals: healthcare situation 2 Years after SARS-CoV-2 infection. Viruses. 2023;15(6) doi: 10.3390/v15061326.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15061326</ArticleId><ArticleId IdType="pmc">PMC10303962</ArticleId><ArticleId IdType="pubmed">37376625</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21(3):133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V., Elghazaly H., Chattopadhyay R., et al. Risk factors associated with post-COVID-19 condition: a systematic review and meta-analysis. JAMA Intern. Med. 2023;183(6):566&#x2013;580. doi: 10.1001/jamainternmed.2023.0750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Deer R.R., Rock M.A., Vasilevsky N., et al. Characterizing long COVID: deep phenotype of a complex condition. EBioMedicine. 2021;74 doi: 10.1016/j.ebiom.2021.103722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103722</ArticleId><ArticleId IdType="pmc">PMC8613500</ArticleId><ArticleId IdType="pubmed">34839263</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder N., Deepak V., Hadique S., et al. Redox imbalance in COVID-19 pathophysiology. Redox Biol. 2022;56 doi: 10.1016/j.redox.2022.102465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2022.102465</ArticleId><ArticleId IdType="pmc">PMC9464257</ArticleId><ArticleId IdType="pubmed">36116160</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul B.D., Lemle M.D., Komaroff A.L., Snyder S.H. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc. Natl. Acad. Sci. U. S. A. 2021;118(34) doi: 10.1073/pnas.2024358118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024358118</ArticleId><ArticleId IdType="pmc">PMC8403932</ArticleId><ArticleId IdType="pubmed">34400495</ArticleId></ArticleIdList></Reference><Reference><Citation>McGarry T., Biniecka M., Veale D.J., Fearon U. Hypoxia, oxidative stress and inflammation. Free Radic. Biol. Med. 2018;125:15&#x2013;24. doi: 10.1016/j.freeradbiomed.2018.03.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2018.03.042</ArticleId><ArticleId IdType="pubmed">29601945</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcello A., Civra A., Milan Bonotto R., et al. The cholesterol metabolite 27-hydroxycholesterol inhibits SARS-CoV-2 and is markedly decreased in COVID-19 patients. Redox Biol. 2020;36 doi: 10.1016/j.redox.2020.101682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2020.101682</ArticleId><ArticleId IdType="pmc">PMC7416714</ArticleId><ArticleId IdType="pubmed">32810737</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghzaiel I., Sassi K., Zarrouk A., et al. 7-Ketocholesterol: effects on viral infections and hypothetical contribution in COVID-19. J. Steroid Biochem. Mol. Biol. 2021;212 doi: 10.1016/j.jsbmb.2021.105939.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2021.105939</ArticleId><ArticleId IdType="pmc">PMC8188774</ArticleId><ArticleId IdType="pubmed">34118414</ArticleId></ArticleIdList></Reference><Reference><Citation>Turell L., Radi R., Alvarez B. The thiol pool in human plasma: the central contribution of albumin to redox processes. Free Radic. Biol. Med. 2013;65:244&#x2013;253. doi: 10.1016/j.freeradbiomed.2013.05.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2013.05.050</ArticleId><ArticleId IdType="pmc">PMC3909715</ArticleId><ArticleId IdType="pubmed">23747983</ArticleId></ArticleIdList></Reference><Reference><Citation>Banne A.F., Amiri A., Pero R.W. Reduced level of serum thiols in patients with a diagnosis of active disease. J. Anti Aging Med. 2003;6(4):327&#x2013;334. doi: 10.1089/109454503323028920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/109454503323028920</ArticleId><ArticleId IdType="pubmed">15142434</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgonje A.R., Abdulle A.E., Bourgonje M.F., et al. Serum free sulfhydryl status associates with new-onset chronic kidney disease in the general population. Redox Biol. 2021;48 doi: 10.1016/j.redox.2021.102211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2021.102211</ArticleId><ArticleId IdType="pmc">PMC8671125</ArticleId><ArticleId IdType="pubmed">34896941</ArticleId></ArticleIdList></Reference><Reference><Citation>Boekhoud L., Koeze J., van der Slikke E.C., et al. Acute kidney injury is associated with lowered plasma-free thiol levels. Antioxidants. 2020;9(11):1135. doi: 10.3390/antiox9111135.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9111135</ArticleId><ArticleId IdType="pmc">PMC7696918</ArticleId><ArticleId IdType="pubmed">33207555</ArticleId></ArticleIdList></Reference><Reference><Citation>Spraakman N.A., Coester A.M., Bourgonje A.R., et al. Systemic and renal dynamics of free sulfhydryl groups during living donor kidney transplantation. Int. J. Mol. Sci. 2022;23(17):9789. doi: 10.3390/ijms23179789.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23179789</ArticleId><ArticleId IdType="pmc">PMC9455962</ArticleId><ArticleId IdType="pubmed">36077183</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortese-Krott M.M., Koning A., Kuhnle G.G.C., et al. The reactive species interactome: evolutionary emergence, biological significance, and opportunities for redox metabolomics and personalized medicine. Antioxidants Redox Signal. 2017;27(10):684&#x2013;712. doi: 10.1089/ars.2017.7083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2017.7083</ArticleId><ArticleId IdType="pmc">PMC5576088</ArticleId><ArticleId IdType="pubmed">28398072</ArticleId></ArticleIdList></Reference><Reference><Citation>Malard E., Valable S., Bernaudin M., P&#xe9;r&#xe8;s E., Chatre L. The reactive species interactome in the brain. Antioxidants Redox Signal. 2021;35(14):1176&#x2013;1206. doi: 10.1089/ars.2020.8238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2020.8238</ArticleId><ArticleId IdType="pubmed">34498917</ArticleId></ArticleIdList></Reference><Reference><Citation>Tami A., van der Gun B.T.F., Wold K.I., et al. The COVID HOME study research protocol: prospective cohort study of non-hospitalised COVID-19 patients. PLoS One. 2022;17(11) doi: 10.1371/journal.pone.0273599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0273599</ArticleId><ArticleId IdType="pmc">PMC9632784</ArticleId><ArticleId IdType="pubmed">36327223</ArticleId></ArticleIdList></Reference><Reference><Citation>Docherty A.B., Harrison E.M., Green C.A., et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. Br. Med. J. 2020;369 doi: 10.1136/bmj.m1985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1985</ArticleId><ArticleId IdType="pmc">PMC7243036</ArticleId><ArticleId IdType="pubmed">32444460</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . 6 October 2021. A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus. publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey A.S., Stevens L.A., Schmid C.H., et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 2009;150(9):604&#x2013;612. doi: 10.7326/0003-4819-150-9-200905050-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-150-9-200905050-00006</ArticleId><ArticleId IdType="pmc">PMC2763564</ArticleId><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu M.L., Louie S., Cross C.E., Motchnik P., Halliwell B. Antioxidant protection against hypochlorous acid in human plasma. J. Lab. Clin. Med. 1993;121(2):257&#x2013;262.</Citation><ArticleIdList><ArticleId IdType="pubmed">8381845</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959;82(1):70&#x2013;77. doi: 10.1016/0003-9861(59)90090-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-9861(59)90090-6</ArticleId><ArticleId IdType="pubmed">13650640</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eijk L.E., Tami A., Hillebrands J.L., et al. Mild coronavirus disease 2019 (COVID-19) is marked by systemic oxidative stress: a pilot study. Antioxidants. 2021;10(12):2022. doi: 10.3390/antiox10122022.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10122022</ArticleId><ArticleId IdType="pmc">PMC8698810</ArticleId><ArticleId IdType="pubmed">34943125</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakeim H.K., Al-Rubaye H.T., Al-Hadrawi D.S., Almulla A.F., Maes M. Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: a proof of concept and mechanism study. Mol. Psychiatr. 2023;28(2):564&#x2013;578. doi: 10.1038/s41380-022-01836-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01836-9</ArticleId><ArticleId IdType="pmc">PMC9589528</ArticleId><ArticleId IdType="pubmed">36280755</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatr. 2021;8(5):416&#x2013;427. doi: 10.1016/s2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G., Maes M. Oxidative and nitrosative stress and immune-inflammatory pathways in patients with myalgic encephalomyelitis (ME)/Chronic fatigue syndrome (CFS) Curr. Neuropharmacol. 2014;12(2):168&#x2013;185. doi: 10.2174/1570159x11666131120224653.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159x11666131120224653</ArticleId><ArticleId IdType="pmc">PMC3964747</ArticleId><ArticleId IdType="pubmed">24669210</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M., Galecki P., Chang Y.S., Berk M. A review on the oxidative and nitrosative stress (O&amp;NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2011;35(3):676&#x2013;692. doi: 10.1016/j.pnpbp.2010.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2010.05.004</ArticleId><ArticleId IdType="pubmed">20471444</ArticleId></ArticleIdList></Reference><Reference><Citation>De Pascali F., Hemann C., Samons K., Chen C.A., Zweier J.L. Hypoxia and reoxygenation induce endothelial nitric oxide synthase uncoupling in endothelial cells through tetrahydrobiopterin depletion and S-glutathionylation. Biochemistry. 2014;53(22):3679&#x2013;3688. doi: 10.1021/bi500076r.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi500076r</ArticleId><ArticleId IdType="pmc">PMC4053070</ArticleId><ArticleId IdType="pubmed">24758136</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieczfinska J., Kleniewska P., Pawliczak R. Oxidative stress-related mechanisms in SARS-CoV-2 infections. Oxid. Med. Cell. Longev. 2022 doi: 10.1155/2022/5589089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/5589089</ArticleId><ArticleId IdType="pmc">PMC8906126</ArticleId><ArticleId IdType="pubmed">35281470</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgonje A.R., Abdulle A.E., Al-Rawas A.M., et al. Systemic oxidative stress is increased in postmenopausal women and independently associates with homocysteine levels. Int. J. Mol. Sci. 2020;21(1) doi: 10.3390/ijms21010314.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21010314</ArticleId><ArticleId IdType="pmc">PMC6982320</ArticleId><ArticleId IdType="pubmed">31906485</ArticleId></ArticleIdList></Reference><Reference><Citation>Frenay A.S., de Borst M.H., Bachtler M., et al. Serum free sulfhydryl status is associated with patient and graft survival in renal transplant recipients. Free Radic. Biol. Med. 2016;99:345&#x2013;351. doi: 10.1016/j.freeradbiomed.2016.08.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2016.08.024</ArticleId><ArticleId IdType="pubmed">27554970</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgonje M.F., Bourgonje A.R., Abdulle A.E., et al. Systemic oxidative stress, aging and the risk of cardiovascular events in the general female population. Front Cardiovasc Med. 2021;8 doi: 10.3389/fcvm.2021.630543.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.630543</ArticleId><ArticleId IdType="pmc">PMC7900172</ArticleId><ArticleId IdType="pubmed">33634173</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgonje A.R., Gabri&#xeb;ls R.Y., de Borst M.H., et al. Serum free thiols are superior to fecal calprotectin in reflecting endoscopic disease activity in inflammatory bowel disease. Antioxidants. 2019;8(9) doi: 10.3390/antiox8090351.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox8090351</ArticleId><ArticleId IdType="pmc">PMC6769968</ArticleId><ArticleId IdType="pubmed">31480545</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Slikke E.C., Boekhoud L., Bourgonje A.R., et al. Plasma free thiol levels during early sepsis predict future renal function decline. Antioxidants. 2022;11(5) doi: 10.3390/antiox11050800.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11050800</ArticleId><ArticleId IdType="pmc">PMC9137477</ArticleId><ArticleId IdType="pubmed">35624664</ArticleId></ArticleIdList></Reference><Reference><Citation>Anraku M., Chuang V.T., Maruyama T., Otagiri M. Redox properties of serum albumin. Biochim. Biophys. Acta. 2013;1830(12):5465&#x2013;5472. doi: 10.1016/j.bbagen.2013.04.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2013.04.036</ArticleId><ArticleId IdType="pubmed">23644037</ArticleId></ArticleIdList></Reference><Reference><Citation>Hortin G.L., Sviridov D., Anderson N.L. High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance. Clin. Chem. 2008;54(10):1608&#x2013;1616. doi: 10.1373/clinchem.2008.108175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2008.108175</ArticleId><ArticleId IdType="pubmed">18687737</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgonje A.R., Geertsema S., Holstein H.J., et al. Evaluating serum free thiols in inflammatory bowel disease: contribution of albumin to extracellular free thiol status. Inflamm. Bowel Dis. 2024 doi: 10.1093/ibd/izae102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ibd/izae102</ArticleId><ArticleId IdType="pubmed">38703063</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller S.A., Isaaka L., Mumm R., et al. Prevalence and risk factors for long COVID and post-COVID-19 condition in Africa: a systematic review. Lancet Global Health. 2023;11(11):e1713&#x2013;e1724. doi: 10.1016/s2214-109x(23)00384-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2214-109x(23)00384-4</ArticleId><ArticleId IdType="pubmed">37858583</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith P., Charafeddine R., Drieskens S., et al. COVIMPACT Studie: Long COVID en de lichamelijke, psychische en sociale gevolgen &#x2013; Resultaten van 3 maanden opvolging. Sciensano. 2021 doi: 10.25608/gqcw-yk36.</Citation><ArticleIdList><ArticleId IdType="doi">10.25608/gqcw-yk36</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan N., Javed Z., Acquah I., et al. Low educational attainment is associated with higher all-cause and cardiovascular mortality in the United States adult population. BMC Publ. Health. 2023;23(1):900. doi: 10.1186/s12889-023-15621-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-023-15621-y</ArticleId><ArticleId IdType="pmc">PMC10186682</ArticleId><ArticleId IdType="pubmed">37193999</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnani J.W., Ning H., Wilkins J.T., Lloyd-Jones D.M., Allen N.B. Educational attainment and lifetime risk of cardiovascular disease. JAMA Cardiol. 2024;9(1):45&#x2013;54. doi: 10.1001/jamacardio.2023.3990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2023.3990</ArticleId><ArticleId IdType="pmc">PMC10620672</ArticleId><ArticleId IdType="pubmed">37910110</ArticleId></ArticleIdList></Reference><Reference><Citation>IHME-CHAINCollaborators Effects of education on adult mortality: a global systematic review and meta-analysis. Lancet Public Health. 2024;9(3):e155&#x2013;e165. doi: 10.1016/s2468-2667(23)00306-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2468-2667(23)00306-7</ArticleId><ArticleId IdType="pmc">PMC10901745</ArticleId><ArticleId IdType="pubmed">38278172</ArticleId></ArticleIdList></Reference><Reference><Citation>Brahmi F., Vejux A., Ghzaiel I., et al. Role of diet and nutrients in SARS-CoV-2 infection: incidence on oxidative stress, inflammatory status and viral production. Nutrients. 2022;14(11) doi: 10.3390/nu14112194.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14112194</ArticleId><ArticleId IdType="pmc">PMC9182601</ArticleId><ArticleId IdType="pubmed">35683996</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgonje A.R., Offringa A.K., van Eijk L.E., et al. N-acetylcysteine and hydrogen sulfide in coronavirus disease 2019. Antioxidants Redox Signal. 2021 doi: 10.1089/ars.2020.8247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2020.8247</ArticleId><ArticleId IdType="pubmed">33607929</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgonje A.R., Abdulle A.E., Timens W., et al. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19) J. Pathol. 2020;251(3):228&#x2013;248. doi: 10.1002/path.5471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5471</ArticleId><ArticleId IdType="pmc">PMC7276767</ArticleId><ArticleId IdType="pubmed">32418199</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eijk L.E., Offringa A.K., Bernal M.E., Bourgonje A.R., van Goor H., Hillebrands J.L. The disease-modifying role of taurine and its therapeutic potential in coronavirus disease 2019 (COVID-19) Adv. Exp. Med. Biol. 2022;1370:3&#x2013;21. doi: 10.1007/978-3-030-93337-1_1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-93337-1_1</ArticleId><ArticleId IdType="pubmed">35882777</ArticleId></ArticleIdList></Reference><Reference><Citation>Lizard G., Gueldry S., Sordet O., et al. Glutathione is implied in the control of 7-ketocholesterol-induced apoptosis, which is associated with radical oxygen species production. Faseb. J. 1998;12(15):1651&#x2013;1663. doi: 10.1096/fasebj.12.15.1651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.12.15.1651</ArticleId><ArticleId IdType="pubmed">9837855</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering A.V., van Zon S.K.R., Olde Hartman T.C., Rosmalen J.G.M. Persistence of somatic symptoms after COVID-19 in The Netherlands: an observational cohort study. Lancet. 2022;400(10350):452&#x2013;461. doi: 10.1016/s0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgonje A.R., Kloska D., Grochot-Prz&#x119;czek A., Feelisch M., Cuadrado A., van Goor H. Personalized redox medicine in inflammatory bowel diseases: an emerging role for HIF-1&#x3b1; and NRF2 as therapeutic targets. Redox Biol. 2023;60 doi: 10.1016/j.redox.2023.102603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2023.102603</ArticleId><ArticleId IdType="pmc">PMC9841059</ArticleId><ArticleId IdType="pubmed">36634466</ArticleId></ArticleIdList></Reference><Reference><Citation>Feelisch M., Cortese-Krott M.M., Santolini J., Wootton S.A., Jackson A.A. Systems redox biology in health and disease. EXCLI J. 2022;21:623&#x2013;646. doi: 10.17179/excli2022-4793.</Citation><ArticleIdList><ArticleId IdType="doi">10.17179/excli2022-4793</ArticleId><ArticleId IdType="pmc">PMC9203981</ArticleId><ArticleId IdType="pubmed">35721574</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>